Diagnostics of pulmonary hypertension: Experiences with 187 patients referred to the VU Medical Centre;Diagnostiek van pulmonale hypertensie: Ervaringen bij 187 patiënten verwezen naar het VU Medisch Centrum

Nederlands Tijdschrift voor Geneeskunde

Volumn 148, Issue 2, 2004, Pages 82-88

  Roeleveld, R J ^a   Boonstra, A B ^a   Voskuyl, A E ^a   Bronzwaer, J G F ^a   Marques, K M ^a   Vonk Noordegraaf, A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PROTOCOL; CONNECTIVE TISSUE DISEASE; HEART ATRIUM SEPTUM DEFECT; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; NETHERLANDS; PULMONARY HYPERTENSION; THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CONNECTIVE TISSUE DISEASES; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; FEMALE; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; THROMBOEMBOLISM; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0347762861     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Rich S, Chomka E, Hasara L, Hart K, Drizd T, Joo E, et al. The prevalence of pulmonary hypertension in the United States. Adult population estimates obtained from measurements of chest roentgenographs from the NHANES II Survey. Chest 1989;96:236-41.
2. Sietsema KE, Simon JI, Wasserman K. Pulmonary hypertension presenting as a panic disorder. Chest 1987;91:910-2.
3. Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 1987;107:216-23.
4. Rich S, editor. Executive summary from the world symposium on primary pulmonary hypertension, 1998. Evian: WHO; 1998.
5. Kuhn KP, Byrne DW, Arbogast PG, Doyle TP, Loyd JE, Robbins IM. Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenol. Am J Respir Crit Care Med 2003;167:580-6.
6. Galie N, Ussia G, Passarelli P, Parlangeli R, Branzi A, Magnani B. Role of pharmacologic tests in the treatment of primary pulmonary hypertension. Am J Cardiol 1995;75:55A-62A.
7. Ricciardi MJ, Bossone E, Bach DS, Armstrong WF, Rubenfire M. Echocardiographic predictors of an adverse response to a nifedipine trial in primary pulmonary hypertension: diminished left ventricular size and leftward ventricular septal bowing. Chest 1999;116:1218-23.
8. Nicod P, Moser KM. Primary pulmonary hypertension. The risk and benefit of lung biopsy. Circulation 1989;80:1486-8.
9. Gaine SP, Rubin LJ. Primary pulmonary hypertension. Lancet 1998;352:719-25.
10. Hansell DM. Small-vessel diseases of the lung: CT-pathologic correlates. Radiology 2002;225:639-53.
11. Vachiery JL, Brimioulle S, Crasset V, Naije R. False-positive diagnosis of pulmonary hypertension by Doppler echocardiography. Eur Respir J 1998;12:1476-8.
12. Arcasoy SM, Christie JD, Ferrari VA, Sutton MS, Zisman DA, Blumenthal NP, et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003;167:735-40.
13. Fisher DC, Fisher EA, Budd JH, Rosen SE, Goldman ME. The incidence of patent foramen ovale in 1.000 consecutive patients. A contrast transesophageal echocardiography study. Chest 1995;107:1504-9.
14. Nootens MT, Berarducci LA, Kaufmann E, Devries S, Rich S. The prevalence and significance of a patent foramen ovale in pulmonary hypertension. Chest 1993;104:1673-5.
15. Holcomb jr BW, Loyd JE, Ely EW, Johnson J, Robbins IM. Pulmonary veno-occlusive disease: a case series and new observations. Chest 2000;118:1671-9.
16. Delcroix M, Kurz X, Walckiers D, Demedts M, Naeije R. High incidence of primary pulmonary hypertension associated with appetite suppressants in Belgium. Eur Respir J 1998;12:271-6.
17. Rich S, Rubin L, Walker AM, Schneeweiss S, Abenhaim L. Anorexigens and pulmonary hypertension in the United States: results from the surveillance of North American pulmonary hypertension. Chest 2000;117:870-4.
18. Hensrud DD, Connolly HM, Grogan M, Miller FA, Bailey KR, Jensen MD. Echocardiographic improvement over time after cessation of use of fenfluramine and phentermine. Mayo Clin Proc 1999;74:1191-7.
19. Evans TW, Gatzoulis MA, Gibbs JS. A National Pulmonary Hypertension Service for England & Wales: an orphan disease is adopted? Thorax 2002;57:471-2.
20. Galie N, Torbicki A. Pulmonary arterial hypertension: new ideas and perspectives. Heart 2001;85:475-80.